Ledger.Open graph →
SEC Form D · filed June 23, 2025

Synaptogenix, Inc

Offering
$5.5M
Sold
$5.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
NEW YORK, NY
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (11)

Robert Weinstein · NEW YORK, NYExecRobert Weinstein · NEW YORK, NYExecJonathan L. Schechter · New York, NYDirectorBruce T. Bernstein · New York, NYDirectorJoshua Silverman · Luxembourg, LuxembourgExec · DirectorWilliam Singer · CHICAGO, ILDirectorMark Scianna · Campbell, CAExecJonathan L. Schechter · New York, NYDirectorBruce T. Bernstein · New York, NYDirectorJoshua Silverman · New York, NYExec · DirectorWilliam Singer · New York, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗